BHS: Beck Hopelessness Scale
Beck Hopelessness Scale · Also known as: BHS, Beck Hopelessness Scale, Hopelessness Assessment
The Beck Hopelessness Scale (BHS) is a 20-item self-report instrument developed by Aaron Beck and colleagues (1974) to measure the degree of hopelessness and pessimism about the future in adolescents and adults. It is grounded in Beck's cognitive theory of depression and suicide and is widely used in clinical, psychiatric, forensic, and research settings to assess suicide risk and identify individuals at elevated risk for self-harm and completed suicide.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
BHS is indicated in psychiatric, emergency medicine, forensic, and clinical psychology settings for suicide risk screening and assessment. It is particularly valuable in individuals presenting with depression, hopelessness, substance abuse, recent loss, or trauma. It is applicable to adolescents and adults with adequate reading comprehension. BHS is used at initial assessment as part of standard suicide risk evaluation, serially during treatment to monitor hopelessness and suicide risk trajectory, and in research examining hopelessness and suicide outcomes.
Strengths & limitations
- Brief (20 items, 5–10 minutes) and straightforward true/false format; accessible to individuals with limited reading ability or acute distress.
- Strong empirical foundation: decades of research demonstrate hopelessness, particularly BHS scores ≥9, as a significant predictor of suicide attempt and completion, outperforming some other suicide risk factors.
- Taps a theoretically important cognitive construct (hopelessness/negative future expectancy) distinct from depression severity; some depressed individuals with low hopelessness have lower suicide risk than those with depression and high hopelessness.
- Extensively validated across diverse populations (psychiatric inpatients, outpatients, incarcerated individuals, medical patients) and cultural groups; translations available in multiple languages.
- Clinically intuitive and readily explained to patients and families; results can facilitate discussion of treatment targets (cognitive therapy for hopelessness) and safety planning.
- Well-studied sensitivity and specificity for suicide risk; BHS ≥9 is widely accepted in clinical practice and forensic settings as a validated risk indicator.
- Self-report measurement vulnerable to social desirability bias; individuals may minimize hopelessness to appear stable to clinicians (particularly relevant in forensic or legal contexts where minimal distress may support release decisions).
- Does not assess behavioral or situational suicide risk factors (access to means, intent, plan specificity); hopelessness alone is insufficient for comprehensive suicide risk assessment.
- Sensitive but not specific: many individuals with BHS scores ≥9 do not attempt suicide; score cannot be used as a sole predictor and requires clinical judgment and integration with additional factors.
- Does not distinguish between static hopelessness and acute fluctuations; may be less sensitive to rapid changes in hopelessness during crisis or acute psychiatric episodes.
- Limited utility in individuals with cognitive impairment, active psychosis, or severe depression affecting concentration; response validity may be compromised in acute crisis states.
- Does not address reasons for living or protective factors against suicide; hopelessness measurement provides only partial suicide risk picture.
Frequently asked
Is a BHS score of 9 or higher definitely predictive of suicide?
No. A BHS score ≥9 indicates elevated hopelessness and substantially increased suicide risk relative to lower scores. However, it is not deterministic: many individuals with BHS ≥9 do not attempt suicide, and suicide can occur with lower hopelessness scores (e.g., in psychotic states with command hallucinations). BHS is one predictor among many in comprehensive suicide risk assessment.
Can hopelessness improve quickly with treatment?
Hopelessness can improve with effective treatment (antidepressant medication, cognitive therapy, behavioral interventions), but improvement is not always immediate. Some individuals show hopelessness reduction within days to weeks; others require longer treatment. The timeline varies by individual and treatment type. It is important not to assume suicide risk has decreased simply because hopelessness begins to improve—early treatment phase can paradoxically increase suicide risk in some individuals.
If someone denies hopelessness on the BHS but appears hopeless clinically, what should I do?
Discrepancy between BHS response and clinical observation warrants clarification. Possible explanations include social desirability (minimizing distress to appear stable), lack of insight during acute crisis, or assessment timing during transiently improved mood. Clinician should explore responses with the patient, conduct direct interview about future expectations, and integrate clinical observation with self-report scores. Behavioral observations (withdrawal, giving away possessions, expressing futility) may supersede questionnaire scores.
Can BHS be used to assess suicide risk in older adults?
Yes. The BHS has been studied in older adults and demonstrates predictive validity for suicide in that population. However, older adults may have different hopelessness profiles (e.g., health-related hopelessness) and suicide risk factors (untreated pain, loss, isolation). Clinical assessment should integrate BHS with age-specific risk factors.
Should BHS be used in forensic settings where individuals might fake low scores?
BHS can be used in forensic settings, but response bias (faking low hopelessness to appear stable) is a recognized concern. Clinicians should compare BHS scores with behavioral observations, incident history, and collateral information. Inconsistency between low BHS scores and documented statements of hopelessness or suicide attempts should prompt clinical investigation and possible re-administration or use of other assessment methods.
Sources
- Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974). The measurement of pessimism: The Hopelessness Scale. Journal of Consulting and Clinical Psychology, 42(6), 861–865. DOI: 10.1037/h0037562 ↗
- Beck, A. T., & Steer, R. A. (2000). Beck Hopelessness Scale (BHS). Psychological Assessment Resources, Inc. link ↗
How to cite this page
ScholarGate. (2026, June 3). Beck Hopelessness Scale. ScholarGate. https://scholargate.app/en/forensic-psychology/beck-hopelessness-scale
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- HCR-20v3Forensic Psychology↔ compare
- NAS-PIForensic Psychology↔ compare
- PCL-SVForensic Psychology↔ compare
- SPSForensic Psychology↔ compare